Daniela Bota - Dissemin

Papers authored by Daniela Bota

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2018 Xiao-Tang Kong, Albert Lai, Jose A. Carrillo, Dan Beverly Fu, Frank Meyskens, Daniela Bota

A Randomized, Phase I/Ii Trial of Ixazomib in Combination With Standard Therapy for Upfront Treatment of Patients With Newly Diagnosed MGMT Methylated Glioblastoma (Gbm) Study Design

Upload

This paper was not found in any repository, but could be made available legally by the author.

Daniela A. Bota

, Jinah Chung, Manisha Dandekar, Jose A. Carrillo, Xiao-Tang Kong, Dan Beverly Fu, Frank P. K. Hsu, Alex H. Schönthal, Florence M. Hofman, Thomas C. Chen, Raphael Zidovetzki, Chrystel Pretto, Ankie Strik, Virgil E. J. C. Schijns, Apostolos Stathopoulos

Atim-28. Phase 2 Study of Erc1671 Plus Bevacizumab vs Bevacizumab Plus Placebo in Recurrent Gbm Interim Results and Correlations With Cd4+ T Lymphocyte Counts

Upload

Daniela A. Bota

, Santosh Kesari, David Piccioni, Dawit Aregawi, Patrick Roth, Roger Stupp, Annick Desjardins, Steven D. Reich, Ileana Elias, Mingyu Li, Nancy Levin, Benjamin Winograd, Warren Mason

ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS

Upload

Daniela Bota

, Santosh Kesari, David Piccioni, Dawit Aregawi, Patrick Roth, Roger Stupp, Annick Desjardins, Steven D. Reich, Ileana Elias, Mingyu Li, Nancy Levin, Benjamin Winograd, Warren Mason

A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS

Upload

Samarjeet Bajwa, Lisa Flanagan, Stephania Hernandez, Dan Beverly Fu, Daniela Bota

, Xiao-Tang Kong

Path-06. Quantitative Analysis of Mgmt Promoter Methylation and Its Prognostic Value in Glioblastoma Multiforme (Gbm) Patients Treated With Alkylating Chemotherapy- Preliminary Report

Upload

Naomi Lomeli, Diana Pearre, Kaijun Di, Daniela Bota

BDNF Enhancement via Ampakines as a Potential Treatment for Chemotherapy-Related Cognitive Impairment

Upload

Xiao-Tang Kong, Albert Lai, Jose A. Carrillo, Dan Beverly Fu, Frank Meyskens, Daniela A. Bota

Actr-10. A Randomized, Phase I/Ii Trial of Ixazomib in Combination With Standard Therapy for Upfront Treatment of Patients With Newly Diagnosed Mgmt Methylated Glioblastoma (Gbm) Study Design

Upload

David B. Keator, Robert G. Bota, Steven L. Small, Daniela A. Bota

Nimg-46. Longitudinal Resting-State Functional Connectivity Confirms Marizomib (Mrz) Crosses the Blood Brain Barrier (Bbb) and Correlates With Hallucination Severity in Recurrent Gbm Patients

Upload

David Tran, Santosh Kesari, Daniela A. Bota

Qolp-15. Safety and Adverse Event Profile of Tumor Treating Fields in Anaplastic Glioma a Post-Marketing Surveillance Analysis

Upload

This paper is made freely available by the publisher.

Alice S. Wang, Ali O. Jamshidi, Nathan Oh, Ronald Sahyouni, Behdokht Nowroozizadeh, Ronald Kim, Frank P. K. Hsu, Daniela Bota

Somatic SMARCB1 Mutation in Sporadic Multiple Meningiomas: Case Report

Download from doi.org

Virgil Schijns, Chrystel Pretto, Anna Strik, Rianne Gloudemans-Rijkers, Laurent Deviller, Denis Pierre, Jinah Chung, Manisha Dandekar, Jose Carrillo, Xiao-Tang Kong, Beverly Fu, Frank Hsu, Florence Hofman, Thomas Chen, Raphael Zidovetzki and 2 other authors

Therapeutic Immunization against Glioblastoma

Download from doi.org

Daniela Bota

Therapeutic Immunization against Glioblastoma

Upload

Timothy J. Brown, Daniela A. Bota

, Martin J. van Den Bent, Paul D. Brown, Elizabeth Maher, Dawit Aregawi, Linda M. Liau, Jan C. Buckner, Michael Weller, Mitchel S. Berger, Michael Glantz

Management of low-grade glioma: a systematic review and meta-analysis

Upload

Jinah Chung, Manisha Dandekar, Jose A. Carrillo, Daniela A. Bota

, Xiao-Tang Kong, Beverly D. Fu, Frank Pk Hsu, Axel H. Schönthal, Florence M. Hofman, Thomas C. Chen, Raphael Zidovetzki, Chrystel Pretto, Ankie Strik, Virgil Ejc Schijns, Apostolos Stathopoulos

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts

Download from doi.org

Linda M. Liau, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Keyoumars Ashkan, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam and 54 other authors

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Download from link.springer.com

G. Zadeh, T. Walbert, J. Perry, J. Zhu, M. Salacz, D. Bota

, L. Kim, F. Iwamoto, K. Petrecca, S. Sully, T. Montellano, T. Kheoh, A. Das, Tf Cloughesy

10 Toca 5: Toca 511 combined with Toca FC versus standard of care in patients undergoing planned resection for recurrent glioblastoma or anaplastic astrocytoma

Download from www.cambridge.org

Catriona H. M. Jamieson, Maria T. Millan, Abla A. Creasey, Geoff Lomax, Mary E. Donohoe, Mark C. Walters, Mehrdad Abedi, Daniela A. Bota

, John A. Zaia, John S. Adams

CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges

Upload

Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam and 54 other authors

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Download from link.springer.com

Daniela Annenelie Bota

, Santosh Kesari, David Eric Piccioni, Dawit Gebremichael Aregawi, Patrick Roth, Roger Stupp, Annick Desjardins, Steven D. Reich, Ileana Elias, Mingyu Li, Nancy Levin, Benjamin Winograd, Warren P. Mason

A phase 1, multicenter, open-label study of marizomib (MRZ) with temozolomide (TMZ) and radiotherapy (RT) in newly diagnosed WHO grade IV malignant glioma (glioblastoma, ndGBM): Dose-escalation results.

Upload

P. Chang

, J. Grinband

, B. D. Weinberg

, M. Bardis

, M. Khy

, G. Cadena

, M.-Y. Su

, S. Cha

, C. G. Filippi

, D. Bota

, P. Baldi

, L. M. Poisson

, R. Jain

, D. Chow

Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas

Download from www.ajnr.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Daniela Bota